Mint (Mitochondria Iron Network Technologies) 

 

Champion in the development of diagnostic and prognostic markers as well as therapeutics for iron-related disorders with a special focus on mitochondrial iron overload notably in neurodegenerative diseases, chronic inflammatory disorders, and cancer.

To find a solution for human health challenges

Skin Cancer

View details

Psoriasis

View details

AMD

View details

CNS

View details

Ongoing R&D

Study Phase

Ongoing R&D

StudyPhase

Robert C. Hider

Ph.D., FRSC

Charareh Pourzand

Ph.D / DSc, FHEA, FRSB

Ron Nourani

Medical industry entrepreneur

Investment opportunities

 

OPEN - Experienced Investors - High Net Worth Individuals (HNWI) / Sophisticated & Professional.

Mint Therapeutics Ltd is open to discussing investment from a range of investors. If you are able to self-certify as either                  an investment professional, HNWI, or sophisticated investor and would like to know more, then please send us an email                or fill out the form for a Callback.

Request callback

Name *
Phone number *
Message *

CLOSED - Seedrs Crowdfunding: As part of our funding round, Mint Therapeutics Ltd gave our community of friends and followers the opportunity to invest in our business and join us on our journey. We aim to become the largest MedTech fundraising round ever on Seedrs.

Contacts

                     17 King Edwards Rd,                                            Ruislip HA4 7AE

                       United Kingdom

Name *
E-mail *
Country *
Your mobile number (optional)
How did you find us? *
How you would like to be contacted ? *
Message *

Back to Top

Reach us through